Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,699.38
(
1.01%
)
US TECH 100
23,920.00
(
-0.40%
)
Dow Jones
46,946.41
(
0.83%
)
Brent Oil
101.29
(
3.04%
)
Bitcoin
74,260.57
(
-0.78%
)
News Focus
News Focus
Post# of 257250
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 63383

Wednesday, 06/11/2008 2:31:30 PM

Wednesday, June 11, 2008 2:31:30 PM

Post# of 257250
Point taken––I’ll stop mentioning LLY’s LY517717 in the same breath as Apixaban and Rivaroxaban because, even in the best case (for LLY), the development program is several years behind. Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up